ABBV
$209.08
Revenue | $15423Mn |
Net Profits | $944Mn |
Net Profit Margins | 6.12% |
Abbvie Inc’s revenue jumped 6.65% since last year same period to $15423Mn in the Q2 2025. On a quarterly growth basis, Abbvie Inc has generated 15.59% jump in its revenue since last 3-months.
Abbvie Inc’s net profit fell -31.09% since last year same period to $944Mn in the Q2 2025. On a quarterly growth basis, Abbvie Inc has generated -26.59% fall in its net profits since last 3-months.
Abbvie Inc’s net profit margin fell -35.39% since last year same period to 6.12% in the Q2 2025. On a quarterly growth basis, Abbvie Inc has generated -36.49% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 3.22 |
EPS Estimate Current Year | 3.22 |
Abbvie Inc’s earning per share (EPS) estimates for the current quarter stand at 3.22 - a 0% jump from last quarter’s estimates.
Abbvie Inc’s earning per share (EPS) estimates for the current year stand at 3.22.
Earning Per Share (EPS) | 2.97 |
Dividend Per Share (DPS) | 1.64 |
Abbvie Inc’s earning per share (EPS) jumped 12.08% since last year same period to 2.97 in the Q2 2025. This indicates that the Abbvie Inc has generated 12.08% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Abbvie Inc declared 1.64 dividend per share during the earnings announcement for Q2 2025.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2025-05-09 | 2.38 | 2.46 | 3.36% |
2025-07-31 | 3.22 | 2.97 | -7.76% |